Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parallel Group, Randomised, Placebo Controlled, Double Blind Oral Assessment of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects

NCT01057927 is registered in ClinicalTrials.gov with Oxagen Ltd as lead sponsor.

NCT NCT01057927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01057927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parallel Group, Randomised, Placebo Controlled, Double Blind Oral Assessment of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
Lead sponsor
Oxagen Ltd
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
November 30, 2007
Enrollment
132 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

asthma